Presented at ASM Microbe, San Francisco, June 2019
Shapiro AB, Moussa SH, Carter NM, Gao N and Miller AA (Microbe 2019)
Program(s): etx0282
Novel Therapies Targeting Drug-Resistant Gonorrhea
Mueller JP (Microbe 2019)
Program(s): zoliflodacin (etx0914)
Scientific Overview of Entasis Pipeline
Tommasi R (Microbe 2019)
McLeod S, Carter N, Moussa S, Mueller J, Tommasi R and Miller A (Microbe 2019)
Program(s): etx0282
O'Donnell J (Microbe 2019)
Program(s): durlobactam (etx2514)
McLeod S, Huband M, Edah Y, Tommasi R and Miller A (Microbe 2019)
Program(s): durlobactam (etx2514)
Presented at ECCMID, Amsterdam, April 2019
Onufrak NJ, Rubino CM, Ambrose PG, Isaacs R, Srinivasan S and O'Donnell J (ECCMID 2019)
Program(s): durlobactam (etx2514)
Srinivasan S (ECCMID 2019))
Program(s): durlobactam (etx2514)
Efficacy of Cefpodoxime Proxetil and ETX0282 in a Murine UTI Model with E. coli and K. pneumoniae
Weiss WJ, Carter K, Pulse ME, Nguyen P, Valtierra D, Peterson K, Tommasi R, Mueller JP, O'Donnell J (ECCMID 2019)
Program(s): etx0282
Durand-Reville T (ECCMID 2019)
McLeod S, Moussa S, Huband M, Mueller J, Tommasi R and Miller A (ECCMID 2019)
Program(s): etx0282
McLeod S, Moussa S, Hackel M, Tommasi R and Miller A (ECCMID 2019)
Program(s): durlobactam (etx2514)
Seifert H, Stefanik, D, Muller C, Higgins P, Kresken M and Miller A (ECCMID 2019)
Program(s): durlobactam (etx2514)
Presented at ID Week, San Francisco, October 2018
ETX2514SUL (Sulbactam/ETX2514) for The Treatment of Acinetobacter baumannii Infection
Isaacs R (IDWeek 2018)
Program(s): durlobactam (etx2514)